Delivery Order SPE2DB20D2104-SPE2DB25FMNDT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,531.93 to supply Belsomra 20 mg tablets (30-count units). The contract, issued on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,219.25 by the Defense Logistics Agency on December 18, 2025, for the supply of Belsomra 20 mg tablets (30-count packaging). This firm fixed-price, non-competitive set-aside contract is scheduled for completion by December 19, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.84 to AmerisourceBergen Drug Corp for Belsomra 20 mg tablets (30-count) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,433.62 to supply Belsomra 10 mg tablets (30-count units) with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Belsomra 20 mg tablets (30-count) under a firm fixed-price contract type. The award, made on September 19, 2025, carries a ceiling value of $1,524.46 and is scheduled for completion by September 22, 2025. This competitively awarded delivery order contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Belsomra 5 mg tablets (30-count) valued at $1,079.02. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- Defense Logistics Agency awarded a $381 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the purchase of Belsomra 20 mg tablets. The contract has no set-aside designation and requires delivery to a location in Conshohocken, Pennsylvania by September 29, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense and other federal agencies, this order for a sleep medication supports the...
- The Defense Logistics Agency Troop Support Medical awarded a $127,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes of the 10mg Belsomra sleep aid medication. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by September 15, 2023. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, though further details about the underlying contract...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $712 to Amerisourcebergen Drug Corporation for 30 tablets of the pharmaceutical product Belsomra 10mg. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on September 1, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will serve as the prime contractor for this...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMNDTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,024.62 to AmerisourceBergen Drug Corp for the supply of Belsomra (suvorexant) 20 mg tablets in a 30-count package. The contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizes firm fixed price pricing with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's performance location is based at its corporate office in Conshohocken. This contract aligns with DLA's strategy to maintain reliable pharmaceutical supply chains for the Defense Health Agency and other federal healthcare customers through competitively awarded delivery orders under the broader pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/6/25 |